National Journal of Pharmaceutical Sciences
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9262, E-ISSN: 2788-9270

National Journal of Pharmaceutical Sciences


2022, Vol. 2, Issue 2, Part B
A review on schizophrenia: Drugs, treatment and therapy approaches


Author(s): Zinatakhtar Saduwala, Nayana Chandrasekhar and Dr. Umesh Upadhyay

Abstract: Schizophrenia is one of the most serious neuropsychiatric illnesses, characterized by hallucinations, delusions, and cognitive issues. It is a complicated life disabling psychotic disease, affects 1% of the general population. The pathophysiology of schizophrenia has been related to structural brain changes and neurotransmitters disturbances. Symptoms of schizophrenia are manifested as three main groups; positive, negative, and cognitive symptoms. Effective treatment of schizophrenia is a challenging goal itself; it requires implementation of pharmacological, psychological, and environmental tools. This review has discussed all reported researches and inventions to deliver Second generation Antipsychotics’ (SGAs) like Risperidone, Clozapine, Olanzapine, and Samidorphan, etc. According to recent studies there are various therapy and treatment used to treat schizophrenia without medication including Yoga therapy, Electroconvulsive therapy (ECT), Music therapy, Morita therapy. Primary care is often the first point of contact for people living with mental disorders. Community pharmacists, pharmacy staff and students are increasingly being trained to deliver mental health care. However, there is still a gap in the literature exploring the characteristics of all available mental health training programs and their components and their influence on pharmacists, pharmacy staff and students’ outcomes.

Pages: 122-133 | Views: 90 | Downloads: 73

Download Full Article: Click Here
How to cite this article:
Zinatakhtar Saduwala, Nayana Chandrasekhar, Dr. Umesh Upadhyay. A review on schizophrenia: Drugs, treatment and therapy approaches. Nat J Pharm Sci 2022;2(2):122-133.


National Journal of Pharmaceutical Sciences